Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-23T13:19:38.411Z Has data issue: false hasContentIssue false
  • English
  • Français

Brain energy metabolism is increased by chronic administration of bupropion

Published online by Cambridge University Press:  24 June 2014

Gabriela K. Ferreira ,
Gislaine T. Rezin ,
Mariane R. Cardoso ,
Cinara L. Gonçalves ,
Lislaine S. Borges ,
Júlia S. Vieira ,
Lara M. Gomes ,
Alexandra I. Zugno ,
João Quevedo  and
Emilio L. Streck
Gabriela K. Ferreira
Affiliation:
Laboratório de Bioenergética, Programa de Pós-graduação em Ciências da Saúde, Universidade do Extremo Sul Catarinense, Criciúma, SC, Brazil Instituto Nacional de Ciência e Tecnologia em Medicina Translacional, do Extremo Sul Catarinense, Criciúma, SC, Brazil
Gislaine T. Rezin
Affiliation:
Laboratório de Bioenergética, Programa de Pós-graduação em Ciências da Saúde, Universidade do Extremo Sul Catarinense, Criciúma, SC, Brazil Instituto Nacional de Ciência e Tecnologia em Medicina Translacional, do Extremo Sul Catarinense, Criciúma, SC, Brazil
Mariane R. Cardoso
Affiliation:
Laboratório de Bioenergética, Programa de Pós-graduação em Ciências da Saúde, Universidade do Extremo Sul Catarinense, Criciúma, SC, Brazil Instituto Nacional de Ciência e Tecnologia em Medicina Translacional, do Extremo Sul Catarinense, Criciúma, SC, Brazil
Cinara L. Gonçalves
Affiliation:
Laboratório de Bioenergética, Programa de Pós-graduação em Ciências da Saúde, Universidade do Extremo Sul Catarinense, Criciúma, SC, Brazil Instituto Nacional de Ciência e Tecnologia em Medicina Translacional, do Extremo Sul Catarinense, Criciúma, SC, Brazil
Lislaine S. Borges
Affiliation:
Laboratório de Bioenergética, Programa de Pós-graduação em Ciências da Saúde, Universidade do Extremo Sul Catarinense, Criciúma, SC, Brazil Instituto Nacional de Ciência e Tecnologia em Medicina Translacional, do Extremo Sul Catarinense, Criciúma, SC, Brazil
Júlia S. Vieira
Affiliation:
Laboratório de Bioenergética, Programa de Pós-graduação em Ciências da Saúde, Universidade do Extremo Sul Catarinense, Criciúma, SC, Brazil Instituto Nacional de Ciência e Tecnologia em Medicina Translacional, do Extremo Sul Catarinense, Criciúma, SC, Brazil
Lara M. Gomes
Affiliation:
Laboratório de Bioenergética, Programa de Pós-graduação em Ciências da Saúde, Universidade do Extremo Sul Catarinense, Criciúma, SC, Brazil Instituto Nacional de Ciência e Tecnologia em Medicina Translacional, do Extremo Sul Catarinense, Criciúma, SC, Brazil
Alexandra I. Zugno
Affiliation:
Instituto Nacional de Ciência e Tecnologia em Medicina Translacional, do Extremo Sul Catarinense, Criciúma, SC, Brazil Laboratório de Neurociências, Programa de Pós-graduação em Ciências da Saúde, Universidade do Extremo Sul Catarinense, Criciúma, SC, Brazil
João Quevedo
Affiliation:
Instituto Nacional de Ciência e Tecnologia em Medicina Translacional, do Extremo Sul Catarinense, Criciúma, SC, Brazil Laboratório de Neurociências, Programa de Pós-graduação em Ciências da Saúde, Universidade do Extremo Sul Catarinense, Criciúma, SC, Brazil
Emilio L. Streck*
Affiliation:
Laboratório de Bioenergética, Programa de Pós-graduação em Ciências da Saúde, Universidade do Extremo Sul Catarinense, Criciúma, SC, Brazil Instituto Nacional de Ciência e Tecnologia em Medicina Translacional, do Extremo Sul Catarinense, Criciúma, SC, Brazil
*
Prof. Emilio L. Streck, PharmD, PhD, Laboratório de Bioenergética, Universidade do Extremo Sul Catarinense, 88806-000, Criciúma, SC, Brazil. Tel: +55 48 3431 2539; Fax: +55 48 3431 2750; E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Extract

Objectives: Based on the hypothesis that energy impairment may be involved in the pathophysiology of depression, we evaluated the activities of citrate synthase, malate dehydrogenase, succinate dehydrogenase (SDH), mitochondrial respiratory chain complexes I, II, II-III, IV and creatine kinase (CK) in the brain of rats submitted to chronic administration of bupropion.

Methods: Animals received daily administration of bupropion dissolved in saline (10 mg/kg, intraperitoneal) at 1.0 ml/kg body weight. The rats received injections once a day for 14 days; control rats received an equivalent volume of saline. Twelve hours after the last administration, the rats were killed by decapitation and brain was rapidly removed and kept on an ice plate. The activities of the enzymes were measured in different brain areas.

Results: We observed that the activities of citrate synthase and malate dehydrogenase, mithocondrial respiratory chain complexes I, II-III and IV and CK were not altered after chronic administration of bupropion. However, SDH activity was increased in the prefrontal cortex and cerebellum. In the hippocampus, cerebellum and striatum the activity of complex II was increased after chronic administration of bupropion.

Conclusions: Our results demonstrated that bupropion increased some enzymes of brain energy metabolism. These findings are in accordance with other studies which showed that some antidepressants may improve energy metabolism. The present results reinforce the hypothesis that antidepressants modulate brain energy metabolism.

Keywords

brainbupropioncreatine kinaseKrebs cyclemitochondrial respiratory chain
Type
Research Article
Information
Acta Neuropsychiatrica , Volume 24 , Issue 2 , April 2012 , pp. 115 - 121
Copyright
Copyright © Cambridge University Press 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Rex, A, Schickert, R, Fink, H.Antidepressant-like effect of nicotinamide adenine dinucleotide in the forced swim test rats. Pharmacol Biochem Behav 2004;77:303–307.Google Scholar
2.Murray, CJL. The global burden of disease. In: Murray, CJ, Lopez, AD, eds. Global burden of disease and injury series. Boston, MA: The Harvard School of Public Health, 1996.Google Scholar
3.Shelton, RC.The molecular neurobiology of depression. Psychiatric Clin North Am 2007;30:1–11.Google Scholar
4.Kessler, RC, Gonagle, KA, Zhao, S et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry 1994;51:8–19.Google Scholar
5.Kessler, RC, Rubinow, DR, Holmes, C, Abelson, JM, Zhao, S.The epidemiology of DSM-III-R bipolar disorder in a general population survey. Psychol Med 1997;27: 1079–1089.Google Scholar
6.Longone, P, Rupprecht, R, Manieri, GA, Bernardi, G, Romeo, E, Pasini, A.The complex roles of neurosteroids in depression and anxiety disorders. Neurochem Int 2008;52: 596–601.Google Scholar
7.Mico, JA, Ardid, D, Berrocoso, E, Eschalier, A.Antidepressants and pain. Trends Pharmacol Sci 2006;7:348–354.CrossRefGoogle Scholar
8.Stahl, SM, Pradko, JF, Haight, BR, Modell, JB, Rockett, CB, Learned-Coughlin, S.A review of the neuropharmacology of bupropion, a dual norepinephrin and dopamine reuptake inhibitor. Prim Care Companion J Clin Psychiatry 2004;6:159–166.Google ScholarPubMed
9.Duman, RS, Nakagawa, S, Malberg, J.Regulation of adult neurogenesis by antidepressant treatment. Neuropsychopharmacology 2001;25:836–844.CrossRefGoogle ScholarPubMed
10.Jacobs, BL, Praag, H, Gage, FH.Adult brain neurogenesis and psychiatry: a novel theory of depression. Mol Psychiatry 2000;5:262–269.CrossRefGoogle ScholarPubMed
11.Heales, SJ, Bolaños, JP, Stewart, VC, Brookes, PS, Land, JM, Clark, JB.Nitric oxide, mitochondria and neurological disease. Biochim Biophys Acta 1999;1410:215–228.Google Scholar
12.Blass, JP.Brain metabolism and brain disease: is metabolic deficiency the proximate cause of Alzheimer dementia? J Neurosci Res 2001;66:851–856.CrossRefGoogle ScholarPubMed
13.Schurr, A.Energy metabolism, stress hormones and neural recovery from cerebral ischemia/hypoxia. Neurochem Int 2002;41:1–8.CrossRefGoogle ScholarPubMed
14.Madrigal, JL, Olivenza, R, Moro, MA et al. Glutathione depletion, lipid peroxidation and mitochondrial dysfunction are induced by chronic stress in rat brain. Neuropsychopharmacology 2001;24:420–429.CrossRefGoogle ScholarPubMed
15.Boekema, EJ, Braun, HP.Supramolecular structure of the mitochondrial oxidative phosphorylation system. J Chem Biol 2007;282:1–4.CrossRefGoogle ScholarPubMed
16.Kelly, D, Gordon, J, Alpers, R et al. The tissue-specific expression and developmental regulation of two nuclear genes encoding rat mitochondrial proteins. Medium chain acyl-CoA dehydrogenase and mitochondrial malate dehydrogenase. J Biol Chem 1989;264:18921–18925.CrossRefGoogle ScholarPubMed
17.Corrêa, C, Amboni, G, Assis, LC et al. Effects of lithium and valproate on hippocampus citrate synthase activity in an animal model of mania. Prog Neuropsychopharmacol Biol Psychiatry 2007;31:887–891.CrossRefGoogle Scholar
18.Tyler, D.The mitochondrion in health and diseases. New York: VCH Publishers, 1992.Google Scholar
19.Brennan, WA, Bird, ED, Aprille, JR.Regional mitochondrial respiratory activity in Huntington's disease brain. J Neurochem 1985;44:1948.Google Scholar
20.Heales, SJ, Bolanõs, JP, Stewart, VC, Brookes, PS, Land, JM, Clark, JB.Nitric oxide, mitochondria and neurological disease. Biochim Biophys Acta 1999;1410:215–228.Google Scholar
21.Schurr, A.Energy metabolism, stress hormones and neural recovery from cerebral ischemia/hypoxia. Neurochem Int 2002;41:1–8.CrossRefGoogle ScholarPubMed
22.Monsalve, M, Borniquel, S, Valle, I, Lamas, S.Mitochondrial dysfunction in human pathologies. Front Biosci 2007;12:1131–1153.CrossRefGoogle ScholarPubMed
23.Moreira, PI, Santos, MS, Oliveira, CR.Alzheimer's disease: a lesson from mitochondrial dysfunction. Antioxid Redox Signal 2007;9:1621–1630.Google Scholar
24.Moreira, PI, Santos, MS, Seiça, R, Oliveira, CR.Brain mitochondrial dysfunction as a link between Alzheimer's disease and diabetes. J Neurol Sci 2007;257:206–214.CrossRefGoogle Scholar
25.Bessman, SP, Carpenter, CL.The Creatine-Creatine phosphate energy shuttle. Annu Rev Biochem 1985;54:831–865.Google Scholar
26.Wallimann, T, Wyss, M, Brdiczka, D, Nicolay, K, Eppenberger, HM.Intracellular compartmentation, structure and function of Creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the ‘phosphoCreatine circuit' for cellular energy homeostasis. Biochem J 1992;281: 21–40.CrossRefGoogle ScholarPubMed
27.Streck, EL, Amboni, G, Scaini, G et al. Brain creatine kinase activity in an animal model of mania. Life Sci 2008; 82:424–429.Google Scholar
28.Burigo, M, Roza, CA, Bassani, C et al. Decreased Creatine kinase activity caused by electroconvulsive shock. Neurochem Res 2006;31:877–881.CrossRefGoogle ScholarPubMed
29.Kanarick, M, Matrov, D, Kõiv, K, Eller, M, Tõnissaar, M, Harro, J.Changes in regional long-term oxidative metabolism induced by partial serotonergic denervation and chronic variable stress in rat brain. Neurochem Int 2008;52: 432–437.CrossRefGoogle Scholar
30.Stanyer, L, Jorgensen, W, Hori, O, Clark, JB, Heales, SJ.Inactivation of brain mitochondrial Lon protease by peroxynitrite precedes electron transport chain dysfunction. Neurochem Int 2008;53:95–101.Google Scholar
31.Kitamira, Y, Fujitani, Y, Kitagawa, K et al. Effects of imipramine and bupropion on the duration of immobility of acth-treated rats in the forced swim test: involvement of the expression of 5-HT2A receptor mRNA. Biol Pharm Bull 2008;31:246–249.Google Scholar
32.Lowry, OH, Rosebough, NG, Farr, AL et al. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193:265–275.Google Scholar
33.Shepherd, D, Garland, PB.The kinetic properties of citrate synthase from rat liver mitochondria. Biochem J 1969;114:597–610.CrossRefGoogle ScholarPubMed
34.Kitto, GB.Intra- and extramitochondrial malate dehydrogenases from chicken and tuna heart. Meth Enzymol 1969;XIII:106–116.Google Scholar
35.Fischer, JC, Ruitenbeek, W, Berden, JA et al. Differential investigation of the capacity of succinate oxidation in human skeletal muscle. Clin Chim Acta 1985;153:23–26.Google Scholar
36.Cassina, A, Radi, R.Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport. Arch Biochem Biophys 1996;328:309–316.Google Scholar
37.Rustin, P, Chretien, D, Bourgeron, T et al. Biochemical and molecular investigations in respiratory chain deficiencies. Clin Chim Acta 1994;228:35–51.CrossRefGoogle ScholarPubMed
38.Hughes, BP.A method for estimation of serum creatine kinase and its use in comparing creatine kinase and aldolase activity in normal and pathologic sera. Clin Chim Acta 1962;7:597–604.Google Scholar
39.Arnaiz, SL, Coronel, MF, Boveris, A.Nitric oxide, superoxide and hydrogen peroxide production in brain mitochondria after haloperidol treatment. Nitric Oxide 1999;3: 235–243.CrossRefGoogle ScholarPubMed
40.Adam-Vizi, V.Production of reactive oxygen species in brain mitochondria: contribution by electron transport chain and non-electron transport chain sources. Antioxid Redox Signal 2005;7:1140–1149.Google Scholar
41.Assis, LC, Rezin, GT, Comim, CM et al. Effect of acute administration of ketamine and imipramine on creatine kinase activity in the brain of rats. Rev Bras Psiquiatr 2009; 31:247–252.Google Scholar
42.Scaini, G, Santos, PM, Benedet, J et al. Evaluation of krebs cycle enzymes in the brain of rats after chronic administration of antidepressants. Brain Res Bull 2010;52: 224–227.Google Scholar
43.Gardner, A, Johansson, A, Wibom, R et al. Alterations of mitochondrial function and correlations with personality traits in selected major depressive disorder patients. J Affect Dis 2003;76:55–68.CrossRefGoogle ScholarPubMed
44.Madrigal, JL, Olivenza, R, Moro, MA et al. Glutathione depletion, lipid peroxidation and mitochondrial dysfunction are induced by chronic stress in rat brain. Neuropsychopharmacology 2001;24:420–429.CrossRefGoogle ScholarPubMed
45.Rezin, GT, Cardoso, MR, Gonçalves, CL et al. Inhibition of mitochondrial respiratory chain in brain of rats subjected to an experimental model of depression. Neurochem Int 2008;53:395–400.Google Scholar
46.Wellman, PJ.Modulation of eating by central catecholamine systems. Curr Drug Targets 2005;6:191–199.Google Scholar
47.Ascher, JA, Cole, JO, Colin, JN et al. Bupropion: a review of its mechanism of antidepressant activity. J Clin Psychiatry 1995;56:395–401.Google Scholar
48.Stahl, SM, Pradko, JF, Haight, BR, Modell, JG, Rockett, CB, Learned-Coughlin, S.A review of the neuropharmacology of bupropion, a dual norepinephrine and dopamine reuptake inhibitor. Prim Care Companion J Clin Psychiatry 2004;6:159–166.Google ScholarPubMed
49.Scaini, G, Maggi, DD, De-Nês, BT et al. Activity of mitochondrial respiratory chain is increased by chronic administration of antidepressants. Acta Neuropsychiatrica 2011; 23:112–118.Google Scholar
50.Santos, PM, Scaini, G, Rezin, GT et al. Brain creatine kinase activity is increased by chronic administration of paroxetine. Brain Res Bull 2009;80:327–330.CrossRefGoogle ScholarPubMed
51.Agostinho, FR, Scaini, G, Ferreira, GK et al. Effects of olanzapine, fluoxetine and olanzapine/fluoxetine on creatine kinase activity in rat brain. Brain Res Bull 2009;80: 337–340.Google Scholar